CA
ALIM

Calton & Associates’s Alimera Sciences ALIM Stock Holding History

Calton & Associates’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-133
Closed -$2K – 1327
2017
Q4 		$2K Buy
+133
New +$2.6K ﹤0.01% 1415

Other funds holding ALIM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Calton & Associates's ALIM Position: Q1 2018 in Review

Calton & Associates sold out of Alimera Sciences (ALIM) in Q1 2018, closing a stake of 133 shares — an estimated $2K sold.

Calton & Associates first reported a position in ALIM in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 40 funds tracked by Wall St. Rank hold ALIM as of Q1 2018.

  • Calton & Associates reported no remaining Alimera Sciences position as of Q1 2018 after selling out during the quarter.
  • Calton & Associates sold 133 Alimera Sciences shares in Q1 2018, an estimated $2K.
  • Calton & Associates first reported a position in Alimera Sciences in Q4 2017 and held it in 1 quarter.
  • Calton & Associates's Alimera Sciences position peaked at $2K in Q4 2017.
  • 40 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2018.

Based on Calton & Associates's 13F filing for Q1 2018, filed 17 Apr 2018.